| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysis
|
Cao, Lifen
|
|
|
191 |
1 |
p. 169-176
|
artikel
|
| 2 |
A HER2 target antibody drug conjugate combined with anti-PD-(L)1 treatment eliminates hHER2+ tumors in hPD-1 transgenic mouse model and contributes immune memory formation
|
Huang, Lei
|
|
|
191 |
1 |
p. 51-61
|
artikel
|
| 3 |
Biomarkers of immunotherapy response in breast cancer beyond PD-L1
|
Chic, Nuria
|
|
|
191 |
1 |
p. 39-49
|
artikel
|
| 4 |
Breast reconstruction is a viable option for older patients
|
Dolen, Utku C.
|
|
|
191 |
1 |
p. 77-86
|
artikel
|
| 5 |
Cardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients: a retrospective cohort study in Germany (ESCaRa)
|
Merzenich, Hiltrud
|
|
|
191 |
1 |
p. 147-157
|
artikel
|
| 6 |
Comparison of upper extremity lymphedema after sentinel lymph node biopsy and axillary lymph node dissection: patient-reported outcomes in 3044 patients
|
Poulsen, Lotte
|
|
|
191 |
1 |
p. 87-96
|
artikel
|
| 7 |
Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations
|
Hashimoto Takigami, Naoko
|
|
|
191 |
1 |
p. 221
|
artikel
|
| 8 |
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
|
De Laurentiis, Michelino
|
|
|
191 |
1 |
p. 223-224
|
artikel
|
| 9 |
Correction to: Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer
|
Ren, Megan
|
|
|
191 |
1 |
p. 227
|
artikel
|
| 10 |
Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D)
|
Pondé, Noam
|
|
|
191 |
1 |
p. 225
|
artikel
|
| 11 |
Elevated magnetic resonance imaging measures of adipose tissue deposition in women with breast cancer treatment-related lymphedema
|
Crescenzi, Rachelle
|
|
|
191 |
1 |
p. 115-124
|
artikel
|
| 12 |
KIF21A regulates breast cancer aggressiveness and is prognostic of patient survival and tumor recurrence
|
Lucanus, Anton J.
|
|
|
191 |
1 |
p. 63-75
|
artikel
|
| 13 |
Novel classes of immunotherapy for breast cancer
|
Hernando-Calvo, Alberto
|
|
|
191 |
1 |
p. 15-29
|
artikel
|
| 14 |
Omitting axillary dissection: could we offer a more tailored management to elderly patients with breast cancer?
|
Vargas, Andrés
|
|
|
191 |
1 |
p. 219-220
|
artikel
|
| 15 |
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis
|
Bianco, Nadia
|
|
|
191 |
1 |
p. 137-145
|
artikel
|
| 16 |
Penetrance of male breast cancer susceptibility genes: a systematic review
|
Chamseddine, Reem S.
|
|
|
191 |
1 |
p. 31-38
|
artikel
|
| 17 |
Preoperative MRI in breast cancer: effect of breast density on biopsy rate and yield
|
Onega, Tracy
|
|
|
191 |
1 |
p. 177-190
|
artikel
|
| 18 |
Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis
|
Shiino, Sho
|
|
|
191 |
1 |
p. 1-14
|
artikel
|
| 19 |
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer
|
Corbaux, Pauline
|
|
|
191 |
1 |
p. 191-207
|
artikel
|
| 20 |
SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study
|
Baker, Jennifer L.
|
|
|
191 |
1 |
p. 107-114
|
artikel
|
| 21 |
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs
|
Mills, Matthew N.
|
|
|
191 |
1 |
p. 209-217
|
artikel
|
| 22 |
Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up
|
Zheng, Fangchao
|
|
|
191 |
1 |
p. 97-105
|
artikel
|
| 23 |
Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li–Fraumeni syndrome
|
Siegel, Atara
|
|
|
191 |
1 |
p. 159-167
|
artikel
|
| 24 |
Vasomotor symptoms in midlife women with incident breast cancer: pink SWAN
|
Gold, Ellen B.
|
|
|
191 |
1 |
p. 125-135
|
artikel
|
Tijdschrift beschrijving